Pfizer (PFE) Inventory (2009 - 2026)

Pfizer (PFE) has 18 years of Inventory data on file, last reported at $10.7 billion in Q1 2026.

• Quarterly Inventory fell 1.7% year-over-year to $10.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 billion (down 1.7% YoY) and the FY2025 annual result came in at $10.7 billion, down 1.82% from the prior year.
• Inventory held at $10.7 billion in Q1 2026 per PFE's latest filing, from $10.7 billion in the prior quarter.
• Across five years, Inventory topped out at $11.7 billion in Q3 2024 and bottomed at $9.0 billion in Q4 2022.
• The 5-year median for Inventory is $10.7 billion (2025), against an average of $10.6 billion.
• The widest annual swing landed in 2022, when Inventory gained 17.5%; it then slipped 4.39% in 2023.
• Tracing PFE's Inventory over 5 years: stood at $9.0 billion in 2022, then increased by 13.45% to $10.2 billion in 2023, then gained by 6.5% to $10.9 billion in 2024, then declined by 1.82% to $10.7 billion in 2025, then rose by 0.12% to $10.7 billion in 2026.
• Per Business Quant, the three latest PFE Inventory figures stand at $10.7 billion (Q1 2026), $10.7 billion (Q4 2025), and $11.5 billion (Q3 2025).

Peer Comparison